Enric Esmatjes - Concepedia

Author

Enric Esmatjes

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ORCID

Also Known As

E Esmatjes, E Esmatjes Mompó, E. ESMATJES, E. Esmatjes, E. Esmatjes Mompo, E. Esmatjes Mompó, ENRIC ESMATJES, Enric E. Esmatjes, Enric Esmatjes, Enric Esmatjes Mompó

223

Publications

7.6K

Citations

H-Index

116

Concepts

All Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Hospital Clínic de Barcelona Universitat de Barcelona Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas Instituto de Salud Carlos III

About

Enric Esmatjes is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	37	4.6K
2	Health Sciences	6	6	157
3	Public Health	6	6	397
4	Arts	1	1	50
5	Education	1	1	56

Enric Esmatjes

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS Robert Altman, L Carreras, Rubén Sierra Díaz, Oxford University Research Archive (ORA) (University of Oxford) ThrombosisIschemic StrokeCardiovascular DiseaseMedicineBlood Platelet	1994	3.3K
Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Tomás Berl, Lawrence G. Hunsicker, Julia B. Lewis, Annals of Internal Medicine	2003	397
Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial Marc A. Pohl, Samuel S. Blumenthal, D Cordonnier, Journal of the American Society of Nephrology	2005	373
Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial Tomás Berl, Lawrence G. Hunsicker, Julia B. Lewis, Journal of the American Society of Nephrology HypertensionHeart FailureCardiovascular PharmacologyBlood PressureRenal Function	2005	323
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis Emilio Fernández-Egea, Miquel Bernardo, Thomas Donner, The British Journal of Psychiatry	2009	240
Diabetes mellitus after liver transplantation: prevalence and predictive factors Miquel Navasa, Javier Bustamante, Cláudio Augusto Marroni, Journal of Hepatology HepatologySolid Organ TransplantationDiabetesDiabetes MellitusLiver Transplantation	1996	154
Telomere Length and Pulse Pressure in Newly Diagnosed, Antipsychotic-Naive Patients With Nonaffective Psychosis Emilio Fernández-Egea, Miquel Bernardo, Christopher M. Heaphy, Schizophrenia Bulletin	2009	100
Glucose abnormalities in the siblings of people with schizophrenia Emilio Fernández-Egea, Miquel Bernardo, Eduard Parellada, Schizophrenia Research PsychiatryPsychotic DisorderDiabetesSchizophreniaGlucose Abnormalities	2008	95
Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control M. Jansà, M. Vidal, Judith Viaplana, Diabetes Research and Clinical Practice Type 1Diabetes ManagementTelemedicineDiabetesPatient Education	2006	81
The Efficiency of Telemedicine to Optimize Metabolic Control in Patients with Type 1 Diabetes Mellitus: Telemed Study Enric Esmatjes, Margarida Jansà, Daría Roca, Diabetes Technology & Therapeutics	2014	65

Page 1